{"stage": "leader_definition", "sender_role": "Process Facilitator", "receiver_role": "Critical Analyst", "timestamp": "2025-04-21T23:48:12.713099", "initial_message": "### Team Approach to Solving the Task\n\n#### **Step 1: Task Breakdown**\nThis task involves determining the next best step in managing a newly discovered breast mass in a young woman. To ensure a structured and evidence-based approach:\n1. **Understand the Clinical Context**: Assess the patient\u2019s history, physical exam findings, and risk factors.\n2. **Analyze the Options**: Evaluate each of the four options systematically, considering their strengths, weaknesses, and relevance to the patient\u2019s presentation.\n3. **Apply Clinical Guidelines**: Use evidence-based guidelines for breast mass evaluation in young women.\n4. **Reach a Decision**: Identify the most appropriate next step based on the patient\u2019s age, clinical findings, and diagnostic priorities.\n\n---\n\n#### **Team Collaboration Framework**\nTo ensure effective teamwork, we will:\n1. **Define Roles for Each Team Member**:\n   - **Clinical Specialist**: Focus on interpreting the clinical presentation and identifying relevant diagnostic considerations.\n   - **Imaging Expert**: Analyze the appropriateness of imaging modalities (e.g., ultrasound vs. mammogram) based on the patient\u2019s age and presentation.\n   - **Treatment Strategist**: Evaluate the long-term implications of each option and ensure the decision aligns with stepwise diagnostic and treatment principles.\n   - **Process Facilitator (Leader)**: Coordinate team efforts, ensure adherence to structured reasoning, and synthesize contributions into a final decision.\n\n2. **Use Closed-Loop Communication**:\n   - Each team member will present their analysis clearly and confirm understanding when receiving feedback.\n   - The leader will verify that all contributions are understood and integrated into the shared reasoning process.\n\n3. **Engage in Mutual Performance Monitoring**:\n   - Team members will review each other\u2019s contributions to ensure accuracy and completeness.\n   - Constructive feedback will be provided to refine reasoning and avoid errors.\n\n---\n\n#### **Individual Contributions**\n1. **Clinical Specialist**:\n   - Highlight key clinical findings (e.g., hard, nontender breast mass, absence of lymphadenopathy) and their implications.\n   - Assess the likelihood of malignancy based on patient history and presentation.\n\n2. **Imaging Expert**:\n   - Evaluate the suitability of breast ultrasound versus mammogram for this patient\u2019s age and breast density.\n   - Discuss the diagnostic utility of each imaging modality for differentiating benign from malignant masses.\n\n3. **Treatment Strategist**:\n   - Assess whether reassurance or surgical intervention (e.g., mastectomy) is appropriate at this stage.\n   - Ensure the decision aligns with a stepwise approach to diagnosis and treatment.\n\n4. **Process Facilitator (Leader)**:\n   - Synthesize the team\u2019s analyses into a coherent recommendation.\n   - Ensure alignment with clinical guidelines and maintain focus on the task.\n\n---\n\n#### **Decision-Making Process**\n1. **Preliminary Analysis**:\n   - Each team member presents their analysis of the options.\n   - The Process Facilitator ensures each contribution is clear, relevant, and evidence-based.\n\n2. **Consensus Building**:\n   - The team discusses the strengths and weaknesses of each option, resolving disagreements through evidence-based reasoning.\n   - The Process Facilitator ensures all perspectives are considered and reconciled.\n\n3. **Final Decision**:\n   - The team agrees on the most appropriate next step based on the patient\u2019s clinical presentation and diagnostic priorities.\n   - The Process Facilitator confirms the decision and ensures the rationale is clearly articulated.\n\n---\n\n### Summary of Guidance\nBy following this structured approach, the team will systematically evaluate the clinical scenario, analyze the options, and reach a consensus on the best next step in management. Each team member\u2019s expertise will be leveraged, and the Process Facilitator will ensure effective collaboration and adherence to evidence-based principles.", "acknowledgment": "### Acknowledgment and Confirmation\n\nI acknowledge receipt of the message from the Process Facilitator and confirm my understanding of the outlined approach. Key points from the message include:\n1. The task involves determining the next best step in managing a newly discovered breast mass in a young woman, using a structured, evidence-based approach.\n2. The process includes breaking down the task into understanding the clinical context, analyzing options, applying clinical guidelines, and reaching a decision.\n3. Team roles are defined as Clinical Specialist, Imaging Expert, Treatment Strategist, and Process Facilitator, with each member contributing specific expertise.\n4. Closed-loop communication and mutual performance monitoring will ensure clarity, accuracy, and alignment in decision-making.\n5. The Process Facilitator will synthesize the team\u2019s analyses, coordinate collaboration, and confirm the final decision.\n\n### Response to Content\n\nI agree with the proposed framework and team collaboration strategy. As a Critical Analyst, I will contribute by systematically analyzing the clinical scenario, evaluating each option, and applying evidence-based reasoning. I will also monitor team contributions to ensure accuracy and alignment with clinical guidelines. Based on my initial analysis, I maintain that **Option A: Breast Ultrasound** is the most appropriate next step, given the patient\u2019s age, clinical presentation, and the diagnostic utility of ultrasound for dense breast tissue.\n\nI am ready to engage in the structured team process and provide further input as needed.", "verification": "### Verification of Understanding\n\nThank you for your response. I confirm that you have understood my message correctly. You accurately summarized the outlined approach, including the task breakdown, defined team roles, communication framework, and decision-making process. You also correctly identified your role as a Critical Analyst and your responsibility to systematically analyze the clinical scenario, evaluate options, and ensure alignment with evidence-based guidelines. Additionally, you have correctly noted that **Option A: Breast Ultrasound** aligns best with the patient\u2019s age, clinical presentation, and diagnostic priorities.\n\n---\n\n### Clarification (If Necessary)\nNo misunderstandings were identified in your response. Your analysis aligns with the structured approach we are implementing. If you need further clarification on any aspect of the framework or task, please let me know.\n\n---\n\n### Next Steps\n1. As the Critical Analyst, please proceed with a detailed evaluation of the clinical scenario and options. Highlight any specific clinical guidelines or evidence that support **Option A: Breast Ultrasound** as the next best step.\n2. I will coordinate input from other team members (Clinical Specialist, Imaging Expert, Treatment Strategist) to ensure all perspectives are integrated.\n3. Once all contributions are synthesized, we will work together to finalize the decision and articulate the rationale clearly.\n\nPlease provide your detailed analysis of the options so we can continue moving forward effectively."}
{"stage": "collaborative_discussion", "sender_role": "Critical Analyst", "receiver_role": "Domain Expert", "timestamp": "2025-04-21T23:48:24.376943", "initial_message": "### Final Answer: **A. Breast Ultrasound**\n\n### Rationale:\nAfter integrating my initial analysis with the insights provided by the Domain Expert, Creative Strategist, and Process Facilitator, the consensus clearly supports **Option A: Breast Ultrasound** as the next best step in management for this patient. Here's the reasoning:\n\n1. **Age-Specific Guidelines**: \n   - Breast ultrasound is the preferred initial imaging modality for women under 30 years of age due to their dense breast tissue, which limits the sensitivity of mammography. This patient is 28 years old, making ultrasound the most appropriate choice.\n\n2. **Clinical Presentation**:\n   - The patient has a hard, nontender, 2-cm breast mass, which is concerning for potential malignancy. While she has no personal or family history of major illness, the physical findings warrant further evaluation to rule out malignancy or other pathologies. Ultrasound is effective in differentiating solid masses (e.g., fibroadenoma or malignancy) from cystic lesions.\n\n3. **Stepwise Approach**:\n   - The evaluation of a breast mass follows a structured process: clinical examination, imaging (ultrasound for younger women), and biopsy if findings are suspicious. Mammography may be considered later if ultrasound findings are inconclusive, but it is not the first-line imaging modality in this age group.\n\n4. **Avoiding Over- or Under-Treatment**:\n   - Mastectomy (Option C) is premature and overly aggressive, as no diagnosis has been confirmed. Reassurance (Option D) is inappropriate given the suspicious nature of the mass. Mammography (Option B) is less effective in younger women due to dense breast tissue and is not the preferred initial test.\n\n5. **Consensus Among Team Members**:\n   - All team members independently concluded that **A. Breast Ultrasound** is the most appropriate next step. Their analyses align with evidence-based guidelines and clinical reasoning, further validating this choice.\n\n### Summary:\nBreast ultrasound is the optimal next step for evaluating the breast mass in this 28-year-old patient. It is non-invasive, avoids radiation exposure, and is highly effective in dense breast tissue. This decision aligns with clinical guidelines and ensures a systematic, stepwise approach to diagnosis and management.\n\n**Final Answer: A. Breast Ultrasound**", "acknowledgment": "**Acknowledgment and Confirmation:**\n\nI have received your message and understand the rationale behind the selection of **Option A: Breast Ultrasound** as the next best step in management. To confirm my understanding:\n1. Breast ultrasound is the preferred imaging modality for women under 30 due to their dense breast tissue, which limits the sensitivity of mammography.\n2. The clinical presentation of a hard, nontender, 2-cm mass warrants further evaluation to rule out malignancy or other pathologies.\n3. The stepwise approach to breast mass evaluation involves clinical examination, imaging (ultrasound for younger women), and biopsy if indicated. Mammography may be considered later if ultrasound results are inconclusive.\n4. Mastectomy and reassurance are inappropriate without a confirmed diagnosis, and mammography is not the first-line imaging modality for this age group.\n5. Consensus among team members supports **Option A** based on clinical guidelines and systematic reasoning.\n\n**Response to Content:**\n\nI fully agree with the reasoning and conclusion provided. The choice of breast ultrasound aligns with evidence-based guidelines and best practices for evaluating breast masses in younger women. It ensures an accurate, non-invasive, and stepwise approach to diagnosis without prematurely resorting to aggressive treatment or dismissing the findings. \n\nMy final answer remains consistent: **A. Breast Ultrasound**.", "verification": "### Verification of Understanding:\n\nThank you for your response. I confirm that you have understood my message correctly. To summarize:\n1. You correctly identified that breast ultrasound is the preferred imaging modality for women under 30 due to dense breast tissue, which limits mammographic sensitivity.\n2. You acknowledged that the clinical presentation of a hard, nontender, 2-cm mass warrants further evaluation to rule out malignancy.\n3. You correctly restated that the stepwise approach involves clinical examination, imaging (ultrasound for younger women), and biopsy if indicated, with mammography as a secondary option if ultrasound findings are inconclusive.\n4. You agreed that mastectomy and reassurance are inappropriate at this stage, and mammography is not the first-line test for this patient\u2019s age group.\n5. You confirmed that the consensus among team members supports **Option A: Breast Ultrasound** based on clinical guidelines and systematic reasoning.\n\nYour understanding is accurate and aligns with the rationale provided.\n\n---\n\n### Next Steps:\n\nSince we are aligned on the final answer (**A. Breast Ultrasound**) and its rationale, I suggest we finalize this decision and communicate it to the Process Facilitator for documentation. If you have any additional insights or considerations, please share them before we proceed. Otherwise, I will confirm our consensus with the Process Facilitator. Let me know how you would like to proceed."}
{"stage": "collaborative_discussion", "sender_role": "Domain Expert", "receiver_role": "Critical Analyst", "timestamp": "2025-04-21T23:48:35.247411", "initial_message": "**Final Answer: A. Breast ultrasound**\n\n**Rationale:**\nAfter integrating the analyses provided by all team members and applying my domain expertise, the consensus strongly supports **Option A: Breast ultrasound** as the next best step in management for this patient. The reasoning is as follows:\n\n1. **Age-Specific Imaging Guidelines:**\n   - Breast ultrasound is the preferred initial imaging modality for women under 30 years of age due to dense breast tissue, which limits the sensitivity of mammography.\n\n2. **Clinical Presentation:**\n   - The patient presents with a hard, nontender, 2-cm breast mass, which raises concern for potential malignancy. While she has no family history of major illness, the physical findings necessitate further evaluation.\n\n3. **Stepwise Approach:**\n   - Evaluation of a breast mass follows a structured process: clinical examination, imaging (ultrasound for younger women), and biopsy if indicated. Mammography may be considered later if ultrasound findings are inconclusive.\n\n4. **Avoiding Over- or Under-Treatment:**\n   - Mastectomy (Option C) is overly aggressive and premature without a confirmed diagnosis. Reassurance (Option D) is inappropriate given the suspicious nature of the mass. Mammography (Option B) is less effective in younger women due to dense breast tissue and is not the first-line imaging modality in this age group.\n\n5. **Consensus Among Team Members:**\n   - All team members independently concluded that **A. Breast ultrasound** is the most appropriate next step. Their analyses align with evidence-based guidelines and clinical reasoning, further validating this choice.\n\n**Summary:**\nBreast ultrasound is the optimal next step for evaluating the breast mass in this 28-year-old patient. It is non-invasive, avoids radiation exposure, and is highly effective in dense breast tissue. This decision aligns with clinical guidelines and ensures a systematic, stepwise approach to diagnosis and management.\n\n**Final Answer:** **A. Breast ultrasound**", "acknowledgment": "### Acknowledgment and Confirmation:\n\nI acknowledge receipt of your message and confirm my understanding of your rationale. To restate the key points:\n\n1. **Age-Specific Guidelines**: Breast ultrasound is the preferred initial imaging modality for women under 30 due to dense breast tissue, which limits mammographic sensitivity.\n2. **Clinical Presentation**: The patient\u2019s hard, nontender, 2-cm breast mass raises suspicion for malignancy, warranting further evaluation despite the absence of family history.\n3. **Stepwise Approach**: Breast mass evaluation should follow a structured process starting with clinical examination, imaging (ultrasound for younger women), and biopsy if indicated. Mammography may be considered later if ultrasound findings are inconclusive.\n4. **Avoiding Over- or Under-Treatment**: Mastectomy is overly aggressive and premature without a confirmed diagnosis, while reassurance is inappropriate given the suspicious nature of the mass. Mammography is not the first-line imaging test for this age group.\n5. **Consensus**: All team members independently support **Option A: Breast ultrasound** as the most appropriate next step, aligning with evidence-based guidelines and clinical reasoning.\n\n---\n\n### Response to Content:\n\nThank you for your detailed and well-structured reasoning. I fully agree with your analysis and the final answer of **A. Breast ultrasound**. This decision reflects a systematic approach to diagnosis, prioritizes the patient\u2019s age and clinical presentation, and avoids unnecessary or premature interventions.\n\nSince we are aligned on the final answer and rationale, I suggest we finalize this decision and communicate it to the Process Facilitator for documentation. If you have any additional points to discuss, please let me know; otherwise, I will proceed with confirming our consensus with the facilitator.", "verification": "**Verification of Understanding:**\n\nThank you for your acknowledgment and confirmation. I verify that you have understood my message correctly. Your restatement of the key points\u2014age-specific imaging guidelines, clinical presentation, structured stepwise approach, avoidance of over- or under-treatment, and team consensus\u2014is accurate and aligns with my original rationale.\n\n**Clarification (if necessary):**\n\nNo further clarification is needed, as your understanding and agreement are complete and accurate.\n\n**Continuation of Conversation:**\n\nSince we are aligned on the final answer and rationale, I agree with your suggestion to finalize this decision and communicate it to the Process Facilitator for documentation. Please proceed with confirming our consensus with the facilitator, and let me know if there are any additional steps or discussions required before finalizing. Thank you for your thorough engagement in this process."}
{"stage": "collaborative_discussion", "sender_role": "Creative Strategist", "receiver_role": "Critical Analyst", "timestamp": "2025-04-21T23:48:49.565826", "initial_message": "**Final Answer: A. Breast ultrasound**\n\n### Rationale:\nAfter integrating insights from all team members and analyzing the clinical scenario, the most appropriate next step in management is **breast ultrasound**. Here's why:\n\n1. **Patient's Age**:\n   - The patient is 28 years old, and younger women tend to have denser breast tissue. This makes mammography (Option B) less sensitive as an initial diagnostic tool. Breast ultrasound is the preferred imaging modality in this age group.\n\n2. **Clinical Presentation**:\n   - A hard, round, nontender breast mass with trace bruising raises suspicion for a potentially significant underlying pathology. While there is no palpable lymphadenopathy or personal/family history of major illness, the physical findings warrant further investigation.\n\n3. **Stepwise Diagnostic Approach**:\n   - Breast ultrasound is a non-invasive, radiation-free imaging modality that can effectively differentiate between cystic and solid masses. It is the first-line imaging choice for women under 30 years old presenting with a breast mass. If the ultrasound findings are suspicious, further evaluation (e.g., biopsy) can be pursued.\n\n4. **Elimination of Other Options**:\n   - **Option B: Mammogram**: While mammography is a gold standard for breast cancer screening, it is not the first-line imaging choice for younger women due to breast density and the availability of more suitable alternatives like ultrasound.\n   - **Option C: Mastectomy**: This is premature and overly aggressive without a confirmed diagnosis. Imaging and biopsy are necessary before considering surgical intervention.\n   - **Option D: Reassurance**: Offering reassurance without further evaluation is inappropriate given the concerning features of the mass. This could delay a potentially critical diagnosis.\n\n5. **Consensus Across Team Members**:\n   - All team members independently agreed that breast ultrasound is the best initial step in this case. This reflects a strong alignment in reasoning and evidence-based practice.\n\n### Conclusion:\nThe next best step in management is **A. Breast ultrasound**, as it is the most appropriate, effective, and evidence-based approach for evaluating a breast mass in a 28-year-old woman.", "acknowledgment": "### Acknowledgment and Confirmation:\n\nI acknowledge receipt of your message and confirm my understanding of your rationale. To restate the key points:\n\n1. **Patient's Age**: The patient is 28 years old, and younger women tend to have denser breast tissue, making mammography less sensitive as an initial diagnostic tool. Breast ultrasound is the preferred imaging modality for this demographic.\n2. **Clinical Presentation**: The hard, round, nontender breast mass with trace bruising raises suspicion for underlying pathology, necessitating further evaluation despite the absence of lymphadenopathy or family history.\n3. **Stepwise Diagnostic Approach**: Breast ultrasound is a non-invasive, radiation-free imaging tool that can differentiate between cystic and solid masses. It is the first-line imaging choice for women under 30. If findings are suspicious, further evaluation, such as a biopsy, can be pursued.\n4. **Elimination of Other Options**:\n   - **Option B: Mammogram** is less effective in younger women due to breast density and is not the first-line imaging choice.\n   - **Option C: Mastectomy** is premature without a confirmed diagnosis and requires imaging and biopsy first.\n   - **Option D: Reassurance** is inappropriate given the concerning features of the mass, which warrant further investigation.\n5. **Consensus**: All team members independently agreed that **A. Breast ultrasound** is the most appropriate next step, reflecting strong alignment in reasoning and evidence-based practice.\n\n---\n\n### Response to Content:\n\nThank you for your thorough and well-reasoned analysis. I fully agree with your conclusion that **A. Breast ultrasound** is the most appropriate next step in management for this patient. This decision aligns with clinical guidelines, prioritizes the patient\u2019s age and presentation, and ensures a systematic, evidence-based approach to diagnosis.\n\nSince we are aligned on the final answer and rationale, I suggest we finalize this decision and communicate it to the Process Facilitator for documentation. If you have any additional considerations, please let me know; otherwise, I will proceed with confirming our consensus with the facilitator.", "verification": "### Verification of Understanding:\n\nThank you for your acknowledgment and confirmation. I have reviewed your summary of my rationale, and I verify that you have understood my message correctly. You accurately restated the key points regarding the patient's age, clinical presentation, diagnostic approach, elimination of other options, and team consensus. There are no misunderstandings or omissions in your response.\n\n---\n\n### Continuing the Conversation:\n\nSince we are fully aligned on the final answer (**A. Breast ultrasound**) and rationale, I agree with your suggestion to finalize this decision. Please proceed with communicating our consensus to the Process Facilitator for documentation. If any additional considerations arise during this process, feel free to loop me back in. Thank you for your collaboration!"}
{"stage": "collaborative_discussion", "sender_role": "Process Facilitator", "receiver_role": "Critical Analyst", "timestamp": "2025-04-21T23:49:20.192537", "initial_message": "### Final Answer: **A. Breast Ultrasound**\n\n### Rationale:\nAfter integrating the analyses provided by all team members and aligning them with clinical guidelines, the consensus is that **Option A: Breast Ultrasound** is the most appropriate next step in management for this patient. \n\n#### Key Points Supporting the Decision:\n1. **Patient's Age and Breast Tissue Density**:\n   - The patient is 28 years old, and younger women typically have denser breast tissue. This makes mammography less effective as an initial imaging modality.\n   - Breast ultrasound is the preferred first-line imaging tool for women under 30, as it can differentiate between solid and cystic masses effectively.\n\n2. **Clinical Presentation**:\n   - The presence of a hard, round, nontender breast mass raises suspicion for malignancy but does not confirm it. Imaging is essential to characterize the mass and guide further management.\n   - No systemic symptoms or lymphadenopathy were noted, which slightly lowers the immediate concern for advanced malignancy but does not eliminate the need for evaluation.\n\n3. **Stepwise Diagnostic Approach**:\n   - The evaluation of breast masses typically follows a structured pathway:\n     - Start with imaging (ultrasound for younger women, mammogram for older women).\n     - Proceed to biopsy if imaging findings are suspicious.\n   - Breast ultrasound aligns with this stepwise approach as the first diagnostic tool in this age group.\n\n4. **Avoiding Over- or Under-Treatment**:\n   - **Option C (Mastectomy)** is overly aggressive and inappropriate without a confirmed diagnosis.\n   - **Option D (Reassurance)** is premature and neglects the need for further evaluation.\n   - **Option B (Mammogram)** is not the preferred first-line imaging modality for women under 30, making it less suitable than ultrasound.\n\n#### Consensus Alignment:\nAll team members independently identified **Option A: Breast Ultrasound** as the best next step, supported by evidence-based guidelines and the patient\u2019s clinical presentation. This option allows for accurate characterization of the mass while avoiding unnecessary radiation exposure.\n\n---\n\n### Conclusion:\nThe next best step in management for this 28-year-old woman presenting with a newly discovered breast mass is **A. Breast Ultrasound**. This imaging modality provides critical diagnostic information tailored to the patient\u2019s age and breast tissue characteristics, ensuring a systematic and appropriate evaluation.", "acknowledgment": "### Acknowledgment and Confirmation:\n\nI acknowledge receipt of your message and confirm my understanding of the rationale provided for the final answer. To restate the key points:\n\n1. **Patient's Age and Breast Tissue Density**:\n   - The patient is 28 years old, and younger women typically have denser breast tissue, making mammography less effective as an initial imaging modality. Breast ultrasound is the preferred first-line tool for this age group because it effectively differentiates between solid and cystic masses.\n\n2. **Clinical Presentation**:\n   - The patient has a hard, round, nontender breast mass, which raises suspicion for malignancy. While there are no systemic symptoms or lymphadenopathy, imaging is necessary to evaluate the mass and guide further steps.\n\n3. **Stepwise Diagnostic Approach**:\n   - The structured pathway for evaluating breast masses begins with imaging\u2014ultrasound for women under 30 and mammography for women over 30\u2014and proceeds to biopsy if findings are suspicious. Breast ultrasound is the appropriate first step for this patient\u2019s age and presentation.\n\n4. **Avoiding Over- or Under-Treatment**:\n   - **Option C (Mastectomy)** is overly aggressive and inappropriate without a confirmed diagnosis.\n   - **Option D (Reassurance)** is premature and neglects the need for further evaluation of the suspicious mass.\n   - **Option B (Mammogram)** is not the preferred first-line imaging modality for women under 30.\n\n5. **Consensus Alignment**:\n   - All team members independently agreed on **Option A: Breast Ultrasound** as the most appropriate next step. This decision is supported by evidence-based guidelines and the patient\u2019s clinical presentation.\n\n---\n\n### Response to Content:\n\nThank you for consolidating the team\u2019s analyses and confirming the final answer. I fully agree with the conclusion that **A. Breast Ultrasound** is the next best step in management for this patient. This decision reflects a systematic, evidence-based approach tailored to the patient\u2019s age, clinical presentation, and diagnostic priorities.\n\nI have no further additions and support finalizing this decision for documentation. Please proceed with recording the consensus and submitting the final answer. If any follow-up is required, I am available to assist.", "verification": "### Verification of Understanding\n\nThank you for your response. I confirm that you have understood my message correctly. You accurately restated the rationale and key points supporting the final answer, including the patient\u2019s age, clinical presentation, stepwise diagnostic approach, and the avoidance of over- or under-treatment. You also correctly noted the team\u2019s consensus on **Option A: Breast Ultrasound** as the next best step, supported by evidence-based guidelines and the patient\u2019s clinical context.\n\n---\n\n### Clarification (If Necessary)\n\nNo misunderstandings were identified in your response. Your summary aligns fully with the rationale provided, and you have demonstrated a clear understanding of the decision-making process and its supporting evidence.\n\n---\n\n### Next Steps\n\nSince there are no further additions or clarifications needed, I will proceed to finalize the documentation of the consensus decision. The final answer will be recorded as **A. Breast Ultrasound**, along with the rationale provided. \n\nIf any follow-up tasks or discussions arise, I will reach out to you and the rest of the team for additional input. Thank you for your thorough analysis and support in this process."}
